These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31790044)

  • 1. Botulinum Toxin Type A: Evaluation of Onset and Satisfaction.
    Alouf E; Murphy T; Alouf G
    Plast Surg Nurs; 2019; 39(4):148-156. PubMed ID: 31790044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin Type A: Evaluation of Onset and Satisfaction.
    Alouf E; Murphy T; Alouf G
    Plast Surg Nurs; 2018; 38(3):105-113. PubMed ID: 30157123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
    Chang BL; Wilson AJ; Taglienti AJ; Chang CS; Folsom N; Percec I
    Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Baumann L; Brandt FS; Kane MA; Donofrio LM
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S57-65. PubMed ID: 19945006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Comprehensive, Minimally Invasive, Multimodal Aesthetic Treatment on Satisfaction With Facial Appearance: The HARMONY Study.
    Weinkle SH; Werschler WP; Teller CF; Sykes JM; Shamban A; Rivkin A; Narurkar VA; Kaminer MS; Dayan S; Cohen JL; Gallagher CJ
    Aesthet Surg J; 2018 Apr; 38(5):540-556. PubMed ID: 29244069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials.
    Cox SE; Kaufman-Janette J; Cohen JL; Gold M; Joseph J; Nestor MS; Rzany B; Taylor S; Zhou J; Cecerle M; Pueraro E; Irvine R; Dayan S
    Dermatol Surg; 2024 Jun; 50(6):535-541. PubMed ID: 38470985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Dimensional Evaluation of Static and Dynamic Effects of Botulinum Toxin A on Glabellar Frown Lines.
    Rappl T; Wurzer P; May S; Tuca AC; Cambiaso-Daniel J; Parvizi D; Kamolz LP; Lumenta DB
    Aesthetic Plast Surg; 2019 Feb; 43(1):206-212. PubMed ID: 30311033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines.
    Lim JTE; Loh DK; Soh K; Sunga O
    Singapore Med J; 2017 Oct; 58(10):606-609. PubMed ID: 27357317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of neutralizing antibody induction during treatment of glabellar lines with a new US formulation of botulinum neurotoxin type A.
    Lawrence I; Moy R
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S66-71. PubMed ID: 19945007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review of patient-reported satisfaction with botulinum toxin type a for aesthetic procedures.
    Fagien S; Carruthers JDA
    Plast Reconstr Surg; 2008 Dec; 122(6):1915-1925. PubMed ID: 19050545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-perception of natural outcome, appearance, and emotional well-being after OnabotulinumtoxinA treatment for upper facial lines: Post hoc analysis across age and gender.
    Dayan S; Ogilvie P; Boyd C; De Boulle K; Cavallini M; Garcia JK; Musumeci M
    J Cosmet Dermatol; 2024 Jan; 23(1):107-116. PubMed ID: 37616390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Psychometric Validation of the FACE-Q Skin, Lips, and Facial Rhytids Appearance Scales and Adverse Effects Checklists for Cosmetic Procedures.
    Klassen AF; Cano SJ; Schwitzer JA; Baker SB; Carruthers A; Carruthers J; Chapas A; Pusic AL
    JAMA Dermatol; 2016 Apr; 152(4):443-51. PubMed ID: 26934294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
    Beer KR
    Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A.
    Schlessinger J; Monheit G; Kane MA; Mendelsohn N
    Dermatol Surg; 2011 Oct; 37(10):1434-42. PubMed ID: 21745254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines.
    Beer KR; Boyd C; Patel RK; Bowen B; James SP; Brin MF
    J Drugs Dermatol; 2011 Jan; 10(1):39-44. PubMed ID: 21197522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study.
    Molina B; Grangier Y; Mole B; Ribe N; Martín Diaz L; Prager W; Paliargues F; Kerrouche N
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1382-8. PubMed ID: 25495499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plastic surgery training: evaluating patient satisfaction with facial fillers in a resident clinic.
    Iorio ML; Stolle E; Brown BJ; Christian CB; Baker SB
    Aesthetic Plast Surg; 2012 Dec; 36(6):1361-6. PubMed ID: 22986545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.